Re: Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Eur Urol 2009;55:472-81

Eur Urol. 2009 Feb;55(2):e30-1. doi: 10.1016/j.eururo.2008.08.031. Epub 2008 Aug 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use*
  • Calcinosis / pathology
  • Humans
  • Inflammation / physiopathology
  • Male
  • Middle Aged
  • Prostate / anatomy & histology*
  • Prostatic Diseases / pathology
  • Prostatitis / diagnosis
  • Prostatitis / physiopathology
  • Sulfonamides / therapeutic use*
  • Tamsulosin
  • Urinary Bladder, Overactive / drug therapy*
  • Urologic Diseases / drug therapy*

Substances

  • Adrenergic alpha-Antagonists
  • Sulfonamides
  • Tamsulosin